Safety and Efficacy of Intraperitoneal Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis Receiving Systemic Chemotherapy
Phase of Trial: Phase I/II
Latest Information Update: 24 Sep 2019
Price : $35 *
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms IPLUS
- 20 Sep 2019 Planned End Date changed from 29 Jul 2021 to 31 Dec 2021.
- 20 Sep 2019 Planned primary completion date changed from 29 Jul 2020 to 31 Dec 2020.
- 16 Aug 2018 New trial record